News
Outlines strong operational and financial performance driven by the Company’s transformative strategy Warns that Elliott’s ...
Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today ...
Q1 2025 Earnings Call Transcript April 25, 2025 LyondellBasell Industries N.V. beats earnings expectations. Reported EPS is ...
Q1 2025 Earnings Conference Call April 28, 2025 4:00 AM ETCompany ParticipantsUrsula Querette - Head of IRChristian Levin ...
PLC (NASDAQ:SMX) (NASDAQ:SMXWW), a leader in providing "physical to digital" solutions for a circular economy, today unveiled ...
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...
At a live studio broadcast at 09.30 CEST Vattenfall's President and CEO Anna Borg and CFO Kerstin Ahlfont will present the results together with Head of Strategic Development Andreas Regnell. To join ...
12h
Daily Maverick on MSNEskom bets big on renewables with new ‘green’ subsidiaryEskom, with its generation capacity historically dominated by coal technology, is making clear its intentions to enter and ...
Incremental annual margin expansion at HWC and enterprise levels ...
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
Session Name: 652. Oral Abstract Session - Hematologic Malignancies-Plasma Cell Dyscrasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results